Edited by Peter Hillerberg8 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
The week in one paragraph: Earnings season positioning dominated the 518 pulses fired across the ORTEX platform between 5 and 12 October. Short sellers scrambled on both sides of the tape, covering aggressively in some names while piling in elsewhere. A JP Morgan reversal on Bradesco triggered one of the week's sharpest short-covering events, while PTC became the poster child for analyst capitulation after four firms downgraded it in a single day even as the stock finished the week up 37%. Options markets flashed extreme readings on both ends, and convergence alerts clustered around Brazilian financials, healthcare, and the freight sector.
BBD was the most dramatic story. Short interest surged 56% in one week to 24.8 million shares. The trigger was a JP Morgan upgrade to Overweight, reversing the same firm's November 2024 downgrade. The stock rose 29.3% over the week. Bears scrambled to cover.
UFO saw short interest jump 41% in a single day to 22% of float. Availability collapsed 90% to just 26%. A single session move of that magnitude signals a rapid, concentrated build.
EMAT added 37% to its short position over the week. Borrow cost climbed to 32.2% and availability fell to 12.8%. Those are conditions that limit further shorting.
WK short interest rose 24% to 8.8% of float despite an activist accumulation and analyst upgrades flagging upside conviction. Bears are building against the bullish narrative.
On the other side: AHG short interest collapsed 53% in one week to just 0.013% of float, reversing a spike from late September. Borrow costs remain elevated at 16.6% despite negligible short positioning. NMR shorts fell 52% to 954,000 shares as borrow costs dropped to 1.6% and availability soared to 2,372% of short interest. UNG short interest fell 25.3% to 9.3% of float as availability rebounded sharply.
PTC produced the week's most striking analyst event. Rosenblatt, Barclays, RBC, and KeyBanc all cut their ratings on the same day. Then BMO Capital downgraded while raising its target to $205. Oppenheimer followed with its own downgrade as the stock surged 33% in a single session. By week's end, consensus stood at 2 Buy, 15 Hold, mean target $196.67, near the $192 price. Retail attention hit 6.67 standard deviations above its 90-day average, per ORTEX Alt Data.
OPCH was downgraded by five separate firms in a single day. Barrington, Jefferies, Citizens, JP Morgan, and UBS all moved to neutral or equivalent ratings after the stock surged 33% in a week. Mean target fell to $30.39, just below where the stock closed.
Goldman Sachs upgraded PLTR to Buy with a $230 target. The same session saw Goldman downgrade TYL to Neutral, cutting the target to $345 from $395.
Evercore upgraded NTAP to Outperform, raising its target 43% to $300, citing hybrid cloud momentum. HUM received upgrades from both Cantor Fitzgerald and Baird. Cantor raised its target 53% to $460. Baird went to $596.
MRVL was upgraded to Buy by TD Cowen with a $350 target, up 43% from $245. The stock rose 5.8% on the day of the call.
JBLU received a Citigroup upgrade from Sell to Neutral, though the target was cut to $4.50 from $5.30. Short interest sits at 26.4% of float.
KNF was cut by RBC Capital from Outperform to Sector Perform, with the target slashed 44% to $58 from $103.
PRG generated the most extreme options reading of the week. Its put/call ratio hit 58.86, 4.4 standard deviations above its 20-day mean of 3.99, the highest level in 52 weeks. Options traders are bracing hard ahead of October 28 earnings.
CARG put/call ratio exploded to 22.0, a 52-week high and 4.3 standard deviations above its mean. Defensive positioning is extreme ahead of November earnings.
HCSG put/call ratio hit its highest level in 52 weeks. Earnings are due October 20.
In the opposite direction: CBT put/call ratio plummeted to 0.126, 4.1 standard deviations below its mean. Call buying is overwhelming puts. RPG also flashed extreme call dominance, with its PCR spiking to 0.1078, 4.2 standard deviations above its 20-day mean of 0.026.
PFG put/call ratio surged to 0.5271, 4.3 standard deviations above its mean of 0.314, signalling heavy downside protection buying.
Brazilian financials were the dominant regional theme. BBD shorts surged 56% even as the stock rallied 29.3%. ITUB was downgraded by HSBC on valuation, and its short interest doubled over the period. XP rallied 31% in a single session and 52% over the week, with Itau BBA upgrading to Outperform. The Brazil ETF short book doubled into a 15% rally, per the convergence alerts. Short sellers are fighting a rising tide in Brazilian finance.
US healthcare services saw a cluster of sharp moves. OPCH surged 33% and was then downgraded by five firms in one session. PCRX faced simultaneous downgrades from Needham and Jefferies alongside an upgrade from JP Morgan, with short interest at 18% of float. ALHC was cut to Market Perform by William Blair, down 36% in a month.
In freight and logistics, RXO was upgraded by JP Morgan, TD Cowen, and Jefferies in a single session after rising 22.5% in one day. Short interest stood at 9.3% of float. XPO was upgraded by Citigroup to Buy with a $224 target.
Homebuilder and housing materials names drew concentrated bearish activity. MHK was downgraded by RBC to Underperform with an 11% implied downside, while short interest surged 39% over the past month to 8.1% of float. BLDR was also cut to Sector Perform by RBC, with its target slashed 29.5% to $62.
Several tickers drew signals from three or more pulse types simultaneously.
BBD: JP Morgan reversed its November 2024 downgrade with an Overweight call. Simultaneously, shorts surged 56%. HSBC then downgraded to Hold as the stock climbed 23% in a week. Three pulse types, all pointing to a short-covering event forced by analyst momentum.
STZ: HSBC cut to Hold with a 30% target reduction to $135. Short interest climbed 21% in one month to 5% of float. Freedom Broker upgraded to Buy. Analyst capitulation and building shorts with a contrarian buyer in the mix.
XP: A 52% weekly rally triggered an analyst upgrade race, with alt data retail attention elevated and the Brazil ETF short book doubling into the move.
OPCH: Five analyst downgrades in one day. Options market turned cautious post-surge. Short interest had already been building before the rally, per earlier pulses.
WFC: Options swung toward calls ahead of Q3 earnings while multiple analyst firms cut targets. A divergence between options bulls and analyst caution.
HUBS: Raymond James cut the rating. Borrow costs jumped 62% over the prior period. JP Morgan also downgraded to Neutral, cutting the target to $240.
ORTEX Alt Data led this week with a headline on an extreme nuclear event. An Xcel Energy reactor recorded output 10.0 standard deviations below its own history on 11 October, per the Nuclear Output dataset. XEL has been active in the pulse feed throughout the week.
From the Irish cars dataset (CSO registrations): new battery-electric car licensings in Ireland rose 54% year-on-year in September to 3,074 vehicles. Total new car licensings in Ireland reached 7,326 in September, the largest September figure on record since 2014, per the same dataset. Polestar registered battery-electric vehicles in Washington at a record 44 units in August, the largest reading since tracking began in 2021, per the ORTEX US state registrations data. Polestar's borrow cost tripled this week.
The Austrian cars dataset (Statistik Austria registrations) recorded 28,968 new car registrations in September, the highest September total in eight years.
Korea air traffic data showed record September readings across two metrics: cargo reached 1,245,294 tonnes, the largest September on record since 2023, while international passengers hit 24,862,551, also a record. The Korea Airportal data confirmed record September seat supply for UAL at 42,066 seats, an all-time high for the series. AAL cargo through Seoul hit 729 tonnes, the largest September since 2023. FDX cargo through Korea reached 8,643 tonnes, the highest since the series began in 2023.
The VA lender volume dataset recorded VA loans guaranteed falling for three consecutive months, standing at 43,068 in September, a read on US veterans' mortgage demand. The sustained decline is notable ahead of the upcoming earnings season for mortgage-exposed financials.
Volkswagen India registrations hit a record high in September with 8,439 vehicles, the largest September on record since 2017, per ORTEX India registrations data, even as VOW3 shares fell 15% over the month.
Nissan Netherlands sales tumbled 47.5% year-on-year for the quarter per RDW data, with Dutch new car registrations for Nissan hitting their lowest level since 2011 at 196 vehicles in September. 7201 is already under significant short pressure.
PTC: Analyst consensus reset is incomplete. The stock is trading near the new mean target of $197 after a 37% weekly gain. Any softening could accelerate positioning.
BBD: Short covering was rapid and violent. Whether it continues depends on whether the JP Morgan upgrade reprices further. HSBC's Hold rating puts a cap on enthusiasm.
OPCH: Five downgrades in one session rarely end cleanly. Watch for further short interest changes as the new consensus embeds.
MRNA: ORTEX's Index Rebalance Radar puts the probability of Moderna's addition to MSCI North America, MSCI Kokusai, and MSCI World at 81%. The stock sits 75.2% above the MSCI entry line at $55.78. Forced buying of $3.3 billion is forecast, equal to just 0.8 days of normal volume. The ranking cut-off date is 19 October. The announcement would follow on 11 November.
CHTR: ORTEX puts the chance of Charter Communications being deleted from MSCI World at 65%, with $693 million of forced selling at stake over 2.2 days of volume. The price that decides it is $130.59. The stock is already 26.3% below that line.
ZAL: Zalando sits 7.2% below the MSCI World exit line at 25.52 EUR, with a 51% deletion probability and $343 million of potential selling over 10.6 days of volume. The 19 October cut-off is days away.
NATL: The Brink's acquisition carries an 88% completion probability. If it closes, $558 million of forced selling from the S&P SmallCap 600 index is expected, spread over 17.2 days of volume. Expected effective date is 16 November.
WK: Short interest up 24% with activist and analyst activity pulling in the other direction. A squeeze setup if the bullish case gains traction.
PCRX: Three separate analyst actions in one week, two downgrades and one upgrade, with short interest at 18% of float. Earnings-related volatility is the risk.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
